Cheryl Ho

CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer

Cheryl Ho, Marie-Frédérique D'Amours, Eric Bhang, A. Chan et autres

ca (code pays fourni par la source)

Not Always ICANS: Interpreting Neurotoxicity With Tarlatamab in SCLC

Mirna Hennawy, R. C. Harrison, Cheryl Ho

ca (code pays fourni par la source)

Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer

Liton Devnath, Ian Janzen, Cheryl Ho, Barbara Melosky et autres

ca (code pays fourni par la source)

Association of social isolation with overall survival in cancer patients.

Danlin Zeng, Alan Bates, Bonnie Leung, Cheryl Ho et autres

ca (code pays fourni par la source)

Molecular characterization of salivary cancers: Patterns of genomic alterations and potential for impact on therapeutic choices

Marjan Kamali-Sarvestani, Stephen Yip, Eric Bhang, Fatima Usman et autres

ca (code pays fourni par la source)

Corrigendum to “Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)” [Lung Cancer 210 (2025) 108840]

William J. Phillips, Luna Jia Zhan, Deepro Chowdhury, M. John Gill et autres

ca (code pays fourni par la source)

Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)

William J. Phillips, Luna Jia Zhan, Deepro Chowdhury, M. John Gill et autres

ca, gb (code pays fourni par la source)

Matrix Random Walks and the Lima Bean Law

Bruce K. Driver, Brian C. Hall, Cheryl Ho, Todd Kemp et autres

EP.08.17 Patterns of Recurrence and Eligibility for Salvage Therapy After Curative Intent Treatment for Unresectable Stage III NSCLC

Eric Bhang, Marie-Frédérique D'Amours, Alan Chan, Fatima Usman et autres

Immune checkpoint inhibitors-associated acute kidney injury: a systematic review and meta-analysis of incidence, kidney recovery, and recurrent risk

Cheryl Ho, Nai‐Wen Kang, Tzu-Hsuan Yeh, Min‐Hsiang Chuang et autres

tw (code pays fourni par la source)

Ultrarapid EGFR Testing in Non–Small Cell Lung Carcinoma Patients: Findings From a Canadian Clinical Testing Workflow

Kasey Fitzsimmons, Curtis Hughesman, Reka Pataky, Deirdre Weymann et autres

ca, us (code pays fourni par la source)

2788P Real-world third-line treatment patterns and outcomes for recurrent or extensive stage small cell lung cancer (SCLC) in the Canadian small cell lung cancer database (CASCADE)

M-F. Damours, L.J. Zhan, M. John Gill, K. Khan et autres

ca (code pays fourni par la source)